These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 20152492)

  • 1. Editorial comment.
    Smith AB; Pruthi RS
    Urology; 2010 Feb; 75(2):398. PubMed ID: 20152492
    [No Abstract]   [Full Text] [Related]  

  • 2. Editorial comment on: Prognostic implications of lymphangiogenesis in muscle-invasive transitional cell carcinoma of the bladder.
    Joudi FN
    Eur Urol; 2008 Mar; 53(3):579. PubMed ID: 17804153
    [No Abstract]   [Full Text] [Related]  

  • 3. Editorial comment on: molecular lymph node staging in bladder urothelial carcinoma: impact on survival.
    Froehner M
    Eur Urol; 2008 Dec; 54(6):1371. PubMed ID: 18486320
    [No Abstract]   [Full Text] [Related]  

  • 4. Editorial comment on: molecular lymph node staging in bladder urothelial carcinoma: impact on survival.
    Karl A
    Eur Urol; 2008 Dec; 54(6):1372. PubMed ID: 18486317
    [No Abstract]   [Full Text] [Related]  

  • 5. Does current chemotherapy improve survival of patients with invasive bladder cancer?
    Herr HW
    Urology; 1997 Mar; 49(3):309-12. PubMed ID: 9123690
    [No Abstract]   [Full Text] [Related]  

  • 6. Editorial comment.
    Weizer AZ
    J Urol; 2010 Mar; 183(3):920. PubMed ID: 20083283
    [No Abstract]   [Full Text] [Related]  

  • 7. Editorial comment on: P0 stage at radical cystectomy for bladder cancer is associated with improved outcome independent of traditional clinical risk factors.
    Colombo R
    Eur Urol; 2007 Sep; 52(3):774-5. PubMed ID: 17434255
    [No Abstract]   [Full Text] [Related]  

  • 8. Editorial comment on: P0 stage at radical cystectomy for bladder cancer is associated with improved outcome independent of traditional clinical risk factors.
    Brausi M
    Eur Urol; 2007 Sep; 52(3):775-6. PubMed ID: 17434253
    [No Abstract]   [Full Text] [Related]  

  • 9. Editorial comment.
    Herr HW
    Urology; 2009 Jul; 74(1):166. PubMed ID: 19567298
    [No Abstract]   [Full Text] [Related]  

  • 10. Editorial comment.
    Olsson CA
    Urology; 2009 Jul; 74(1):166. PubMed ID: 19567299
    [No Abstract]   [Full Text] [Related]  

  • 11. Organ conservation and reconstruction in advanced bladder cancer.
    Sternberg CN
    Prog Clin Biol Res; 1991; 370():131-42. PubMed ID: 1924442
    [No Abstract]   [Full Text] [Related]  

  • 12. Bladder cancer: improving care with better classification and risk stratification.
    Lamm D
    J Urol; 2007 Oct; 178(4 Pt 1):1146-7. PubMed ID: 17698132
    [No Abstract]   [Full Text] [Related]  

  • 13. Editorial comment on: Long-term intravesical adjuvant chemotherapy further reduces recurrence rate compared with short-term intravesical chemotherapy and short-term therapy with Bacillus Calmette-Guérin (BCG) in patients with non-muscle-invasive bladder cancer.
    Evans CP
    Eur Urol; 2007 Oct; 52(4):1129-30. PubMed ID: 17383082
    [No Abstract]   [Full Text] [Related]  

  • 14. Editorial comment on: Bladder tumor infiltrating mature dendritic cells and macrophages as predictors of response to bacillus Calmette-Guérin immunotherapy.
    de Reijke TM
    Eur Urol; 2009 Jun; 55(6):1395-6. PubMed ID: 19193488
    [No Abstract]   [Full Text] [Related]  

  • 15. Chemotherapy for invasive bladder cancer: facts and fallacies.
    Raghavan D; Pearson BS; Coorey GJ; Boulas J; Rosen IM; Mameghan H; Learoyd HM; Duval P
    Arch Esp Urol; 1990; 43 Suppl 2():209-14. PubMed ID: 2096781
    [No Abstract]   [Full Text] [Related]  

  • 16. Upper tract transitional cell carcinoma: finding a way forward.
    Clark PE
    Cancer; 2007 Oct; 110(8):1648-9. PubMed ID: 17722110
    [No Abstract]   [Full Text] [Related]  

  • 17. Radical cystectomy--often too late? Yes, but ..
    Studer UE
    Eur Urol; 2006 Dec; 50(6):1129-38. PubMed ID: 16949199
    [No Abstract]   [Full Text] [Related]  

  • 18. Editorial comment on: the value of the UroVysion assay for surveillance of non-muscle-invasive bladder cancer.
    Bubendorf L
    Eur Urol; 2008 Aug; 54(2):407-8. PubMed ID: 18082933
    [No Abstract]   [Full Text] [Related]  

  • 19. Editorial comment on: the value of the UroVysion assay for surveillance of non-muscle-invasive bladder cancer.
    Pycha A
    Eur Urol; 2008 Aug; 54(2):408. PubMed ID: 18082932
    [No Abstract]   [Full Text] [Related]  

  • 20. Re: Serum tumor markers may predict overall and disease specific survival in patients with clinically organ confined invasive bladder cancer. D. Margel, R. Tal and J. Baniel. J Urol 2007; 178: 2297-2301.
    Suzuki K
    J Urol; 2008 Jun; 179(6):2481; author reply 2481. PubMed ID: 18436255
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.